Company intelligence / Profile preview

Humabiologics

Phoenix, Arizona, United Stateshumabiologics.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Humabiologics provides human-derived biomaterials for researchers in regenerative medicine and tissue engineering. Their products include human collagen, gelatin, and extracellular matrices that are used for bioprinting, tissue modeling, disease modeling, and drug screening.

Modalities: Human-derived biomaterials
Industry: Non-Drug Biotech

Partnerships

Shanghai Besto Biotechnology Co., Ltd (distributor in China)[3]

Beyond the preview

Go deeper on Humabiologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humabiologics.

Explore the full profile